
Agilon Health, Inc.
(NYSE) AGL
| Metric | Price | Date |
|---|---|---|
| Last close | USD 129.84 | 2026-07-17 |
| Period | Price return | Price at period start | Period start date |
|---|---|---|---|
| 1 week | +13.05% | USD 114.85 | 2026-07-10 |
| 1 month | +24.05% | USD 104.67 | 2026-06-17 |
| 3 month | +332.08% | USD 30.05 | 2026-04-17 |
| Year to date | +654.12% | USD 17.22 | 2025-12-31 |
| 1 year | +139.34% | USD 54.25 | 2025-07-17 |
| 3 year | -70.24% | USD 436.25 | 2023-07-18 |
| 5 year | -84.77% | USD 852.50 | 2021-07-16 |
| Since inception | -83.25% | USD 775.00 | 2021-04-15 |
Agilon Health, Inc. Financials at a Glance
Market Cap
Revenue (TTM)
Net Income (TTM)
EPS (TTM)
P/E Ratio
Dividend
Beta (Volatility)
Dividend
Beta (Volatility)
Price
Volume
Open
Price
Volume
Open
Previous Close
Daily Range
52-Week Range
Estimated Earnings Date
Dividend
Beta (Volatility)
Price
Volume
Open
Previous Close
Daily Range
52-Week Range
Estimated Earnings Date
AGL News
AGL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Agilon Health, Inc.
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
856
CEO
Steven J. Sell, MBA
Website
www.agilonhealth.comHeadquarters
Westerville, OH 78723, US
AGL Financials
Key Financial Metrics (TTM)
Gross Margin
Operating Margin
Net Income Margin
Return on Equity
Return on Capital
Return on Assets
Earnings Yield
Dividend Yield
Payout Ratio
Stock Overview
Market Cap
Shares Outstanding
Volume
Avg. Volume
Financials (TTM)
Gross Profit
Operating Income
EBITDA
Operating Cash Flow
Capital Expenditure
Free Cash Flow
Cash & ST Invst.
Total Debt
Agilon Health, Inc. Performance Analysis
| Fiscal year | Period end | Revenue | YoY growth |
|---|---|---|---|
| 2022 | 2022-12-31 | USD 2,388,220,000 | 30.3% |
| 2023 | 2023-12-31 | USD 4,316,363,000 | 80.7% |
| 2024 | 2024-12-31 | USD 6,060,530,000 | 40.4% |
| 2025 | 2025-12-31 | USD 5,932,576,000 | -2.1% |
| Fiscal quarter | Period end | QoQ growth |
|---|---|---|
| Q2 | 2025-06-30 | -9.0% |
| Q3 | 2025-09-30 | 2.9% |
| Q4 | 2025-12-31 | 9.3% |
| Q1 | 2026-03-31 | -9.5% |
| Fiscal year | Period end | Diluted EPS | YoY growth |
|---|---|---|---|
| 2022 | 2022-12-31 | USD -6.53 | -74.3% |
| 2023 | 2023-12-31 | USD -13.15 | 101.4% |
| 2024 | 2024-12-31 | USD -15.29 | 16.3% |
| 2025 | 2025-12-31 | USD -24.48 | 60.1% |
| Fiscal quarter | Period end | QoQ growth |
|---|---|---|
| Q2 | 2025-06-30 | -933.3% |
| Q3 | 2025-09-30 | -8.0% |
| Q4 | 2025-12-31 | -70.4% |
| Q1 | 2026-03-31 | 115.7% |
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
-7.3%
Gross Profit
+14.8%
Gross Margin
N/A
Market Cap
N/A
Market Cap/Employee
N/A
Employees
N/A
Net Income
+147.5%
EBITDA
+421.3%
Quarterly Fundamentals
Total Cash
-37.2%
Total Debt
-20.5%
Accounts Receivable
-27.4%
Inventory
N/A
Long Term Debt
+162.9%
Short Term Debt
-57.8%
Return on Assets
N/A
Return on Invested Capital
N/A
Free Cash Flow
+148.1%
Operating Cash Flow
+174.2%
